RYTM RHYTHM PHARMACEUTICALS INC

Ownership history in DRIEHAUS CAPITAL MANAGEMENT LLC  ·  14 quarters on record

This page tracks every 13F SEC filing in which DRIEHAUS CAPITAL MANAGEMENT LLC reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.0% (2025 Q3)
Avg. % of fund
0.41%
First filed
2022 Q3
Last filed
2025 Q4
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,285,222 -98,553 -7.1% 0.93% $137.6M $107.04
2025 Q3 ADDED 1,383,775 +113,823 +9.0% 1.00% $139.7M $100.99
2025 Q2 REDUCED 1,269,952 -188,070 -12.9% 0.64% $80.2M $63.19
2025 Q1 ADDED 1,458,022 +167,047 +12.9% 0.74% $77.2M $52.97
2024 Q4 REDUCED 1,290,975 -8,515 -0.7% 0.60% $72.3M $55.98
2024 Q3 ADDED 1,299,490 +117,120 +9.9% 0.58% $68.1M $52.39
2024 Q2 ADDED 1,182,370 +326,865 +38.2% 0.47% $48.5M $41.06
2024 Q1 ADDED 855,505 +256,600 +42.8% 0.37% $37.1M $43.33
2023 Q4 ADDED 598,905 +324,381 +118.2% 0.33% $27.5M $45.97
2023 Q3 ADDED 274,524 +251,531 +1093.9% 0.08% $6.3M $22.92
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RYTM price (monthly, adj. close)
← Back to DRIEHAUS CAPITAL MANAGEMENT LLC Holdings